812.21 HMGLPTHLATER

CH

Art. 1 Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Purpose

TPA; Chapter 1 General Provisions

Open official source Full Act (141 Articles) Machine-readable Markdown (.md)

Art. 1 TPA · Purpose

The purpose of this Act is to protect human and animal health and to guarantee that only high quality, safe and effective therapeutic products are placed on the market.

It shall furthermore: a. protect the consumers of therapeutic products against fraud; b. help to ensure that the therapeutic products placed on the market are used in accordance with their purpose and in moderation; c. help to ensure that a reliable and well-organised supply of therapeutic products, together with the necessary technical information and advice, is available throughout the country.

In the implementation of this Act, in particular in the enactment of the regulations and in the application to an individual case, it must be ensured that: a. the efficiency and independence of the control of therapeutic products is guaranteed in Switzerland; b. favourable conditions exist for research and development in the therapeutic product sector; c. all players competing in the market fulfil the same legal requirements of safety and quality.

Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Purpose Art. 2 TPA →

Court Decisions Applying This Provision (9)

BV.2024.30 (art. 1 al. 1 LPTh)

Swissmedic Seizure of Unapproved Medications Upheld

Cited to state the primary purpose of the LPTh (protection of human health).

C-2652/2019 (art. 1 al. 1 LPTh)

Imported Medication Seizure and Fee Upheld Due to Excessive Quantity

Établit que le but de la loi sur les produits thérapeutiques est de protéger la santé humaine et animale et de garantir la mise sur le marché de produits de qualité, sûrs et efficaces.

C-1168/2018 (Art. 1 al. 1 LPTh)

Recipient Liable for Fees on Illegal Drug Importation Despite Denial

States the purpose of the LPTh is to protect human and animal health and ensure the marketability of quality, safe, and effective therapeutic products.

C-546/2010 (Art. 1 Abs. 2 Bst. b HMG)

Swissmedic v. Aesthetics Company: Advertising Ban and Website Modifications

Cited to emphasize the importance of moderate use of medicines, especially prescription-only ones.

36.2011.49 · ti (Art. 1 cpv. 1 LATer)

Health Insurance Reimbursement for Off-Label Psoriatic Arthritis Medication

Cited to define the purpose of the Federal Law on Therapeutic Products (quality, safety, and efficacy).

C-6050/2008 (Art. 1 Abs. 1 HMG)

Seizure of Unapproved Medication for Personal Use Upheld

Establishes the purpose of medicinal law to protect human and animal health by ensuring only high-quality, safe, and effective medicines are placed on the market.

VPB 08-0857-4983 (art. 1 LPTh)

Swiss Federal Finance Delegation Report 2007

Defines Swissmedic's mission to protect health by ensuring the quality, safety, and efficacy of therapeutic products.

JAAC 70.21 (Art. 1 al. 3 let. c HMG)

Inhalation Gas Price Hike and Agency Press Release Litigation

Cited as a purpose-related provision to be observed during the enforcement of the HMG, ensuring that competing market partners meet the same legal safety and quality requirements.

36.2011.49 · ti (Art. 1 cpv. 1 LATer)

Cantonal Insurance Court Upholds Denial of Humira Coverage for Psoriatic Arthritis Without Prior DMARD Failure

Cited in the reasoning to describe the purpose of the Federal Act on Therapeutic Products (LATer), concerning the quality, safety, and efficacy of medicinal products.